Clinical Trials Update: Sept. 25, 2006
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
273621
Pfizer Inc&#39;s experimental oral  biotechnology drug axitinib demonstrated substantial anti-tumor  activity in patients with advanced thyroid cancer in a small,  mid-stage clinical trial, according to data released at a major  cancer meeting on Saturday.
402115
Two drugs provide good results in preliminary trials.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
390422
FRIDAY, Nov. 17 (HealthDay News) -- Just-released data from a trial that was stopped early in 2004 for safety reasons is re-igniting debate on the safety of two popular painkillers.
714498
Tropical Medicine in London, in research published online by The Lancet medical journal on Thursday. not new and had been made in many of the product-liability lawsuits filed against Philip Morris.
90428
The Harvard researchers, who summarized their findings in this week&#39;s edition of the Journal of the National Cancer Institute, analyzed data from more than 100,000 participants in two large cohort studies.
122956
Many clinical cancer trials are not published in order to keep industry secrets. A British cancer research group calls for all studies to be published -- even those with marginal results -- so doctors are not misled.
117896
MONDAY, June 25 (HealthDay News) -- New cancer drugs often save lives, but are they cost-effective?
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
535175
BioSante releases more info on the pivotal studies for its lead drug.
736868
The world's biggest drug makers will  unveil plans on Thursday to publish more data about clinical  trials of their medicines in a bid to reassure patients about  their safety, according to industry sources.
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
637665
roundup Plus: RIM touts BlackBerry with Wi-Fi...HP to sell Voltaire's InfiniBand switch...PC shipments up, but revenue less so, study says.
548270
The findings of the 'American-Australian-African trial with DronedarONe In atrial fibrillation or flutter patients for the maintenance of Sinus rhythm' (ADONIS) trial, announced at the annual meeting of the ...
254822
In a clinical trial of about 200 patients, an experimental drug from Eli Lilly lessened schizophrenia symptoms without the serious side effects of current treatments, according to a paper published Sunday in the journal Nature.
367540
WEDNESDAY, Dec. 8 (HealthDayNews) -- Two separate studies offer some good news about two drugs for the treatment of Parkinson's disease.